Multiple Choice
Use the following information to answer the following questions.
CML (chronic myelogenous leukemia) results from a translocation between human chromosomes 9 and 22. The resulting chromosome 22 is significantly shorter than the usual, and it is known as a Philadelphia (Ph') chromosome. The junction at the site of the translocation causes over-expression of a thymine kinase receptor. A new drug (Gleevec or imatinib) has been found to inhibit the disease if the patient is treated early.
-Which of the following would be a reasonably efficient technique for confirming the diagnosis of CML?
A) searching for the number of telomeric sequences on chromosome 22
B) looking for a Ph' chromosome in a peripheral blood smear
C) enzyme assay for thymine kinase activity
D) FISH study to determine the chromosomal location of all chromosome 22 q fragments
E) identification of the disease phenotype in review of the patient's records
Correct Answer:
Verified
Correct Answer:
Verified
Q3: A gene that contains introns can be
Q7: The DNA fragments making up a genomic
Q28: Which of the following sequences in double-stranded
Q41: Use the following information to answer the
Q47: Which of the following techniques used to
Q50: Use Figure 20.3 to answer the following
Q51: Expression of a cloned eukaryotic gene in
Q54: Which of the following is one of
Q57: Genetic engineering is being used by the
Q61: Reproductive cloning of human embryos is generally